aviator
发表于 2025-3-28 17:09:34
U. Wollina,M. Gebhardt,D. Langeques, perioperative therapies, and postoperative management. Current management still heavily relies on pathologic staging that does not always reflect an individual patient’s risk. The genesis and progression of bladder cancer is now increasingly recognized as being a result of alterations in sever
FLINT
发表于 2025-3-28 20:59:00
http://reply.papertrans.cn/39/3829/382805/382805_42.png
柱廊
发表于 2025-3-28 23:22:16
http://reply.papertrans.cn/39/3829/382805/382805_43.png
腐蚀
发表于 2025-3-29 05:30:25
http://reply.papertrans.cn/39/3829/382805/382805_44.png
虚弱
发表于 2025-3-29 11:10:15
,Un hôpital pour la peau à Paris,rall survival of 14 months. Urothelial carcinomas harbor frequent molecular dysregulations including recurrent mutations and copy number alteration, some of which could be potential therapeutic targets. However, no molecularly targeted agents have been approved to date for the treatment of advanced
可互换
发表于 2025-3-29 12:48:56
Nuklearmedizinisch-onkologische Einführungnces in surgical treatment of advanced disease has led to continued improvement in outcomes. Patients with testicular cancer who are treated following the treatment guideline mostly achieved high quality of life and long-term survival. However, patients who were identified as having non-guideline di
享乐主义者
发表于 2025-3-29 18:35:39
http://reply.papertrans.cn/39/3829/382805/382805_47.png
Eulogy
发表于 2025-3-29 22:07:41
https://doi.org/10.1007/978-3-319-93339-9Genitourinary Cancers; Immunotherapy; Small Renal Masses; Molecular Prognostication; Metastatic Renal Ce
Diuretic
发表于 2025-3-30 00:04:15
http://reply.papertrans.cn/39/3829/382805/382805_49.png
摊位
发表于 2025-3-30 05:32:26
Genitourinary Cancers978-3-319-93339-9Series ISSN 0927-3042 Series E-ISSN 2509-8497